Arizona Files Suit Against Insys Therapeutics for Conducting “Deceptive Scheme”

This week, Arizona Attorney General Mark Brnovich charged Insys Therapeutics, the Arizona-based manufacturer of the deadly opioid fentanyl, with engaging in a nationwide scheme that deceived doctors, patients and insurance companies about the safety of Subsys, the company’s sublingual fentanyl spray.

Brnovich believes Insys used deceptive and unfair marketing practices in order to boost company profits at the expense of patients’ safety, Arizona Daily Sun reports.

“Insys lied to insurers, concealed key facts from doctors and patients, and paid doctors sham ‘speaker fees’ in exchange for writing prescriptions, all in order to increase the sales of Subsys, without regard for the health and safety of patients. Insys made hundreds of millions of dollars from its deceptive scheme, but also put countless patients in harm’s way, exposing them to unacceptable and unnecessary risks of addiction and death,” Brnovich stated.

In 2016, Insys donated $500,000 to Arizonans for Responsible Drug Policy, the anti-marijuana group that fought against about beat Prop 205, the initiative to legalize recreational marijuana use in Arizona for adults.

Less than a year later, Insys Therapeutics received preliminary approval from the DEA for Syndros, a synthetic marijuana drug the company created.

Photo: PokerNews